Evozyne
Designs engineered protein therapeutics using an AI-native platform.
aibiotech
Company facts
- Founded
- 2020
- Employees
- 70
- Headquarters
- United States
- Type
- Private
- Funding
- Series B · $81M · 2023
Open positions
2 jobs
8 views last week
Director/Senior Director, Preclinical Program Leadership
North AmericaSenior
United States
Chicago, ILEvozyne is an AI-native biotech company building a new way to design therapeutic proteins. Our generative AI platform was purpose-built to create entirely novel proteins that expand what’s possible beyond traditional…
AI Generative AI Performance Management
22 views last week
Applied AI Research Fellow
North AmericaFellowship
United States
Chicago, ILEvozyne, an AI-native biotech in Chicago, seeks a research fellow to advance its EvoGen generative protein-design platform: benchmarking generative protein models, exploring Bayesian optimization extensions for multi-objective design, and building deep learning methods (VAEs, remote homology) validated against real experimental data.
AI Deep Learning Generative AI Machine Learning